Credit Suisse Ag Abb Vie Inc. Put Options Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

Put Options

18 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $2.43 Million - $3.07 Million	22,600 Added 2.48%	933,900 $126 Million
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $1.61 Million - $1.82 Million	-15,100 Reduced 1.63%	911,300 $98.3 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $39.9 Million - $44.5 Million	-379,300 Reduced 29.05%	926,400 $104 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $41.5 Million - $45.7 Million	-405,500 Reduced 23.7%	1,305,700 $141 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $3 Million - $4.05 Million	37,300 Added 2.23%	1,711,200 $183 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $63.3 Million - $74.3 Million	736,900 Added 78.64%	1,673,900 $147 Million
Q2 2020 Aug 12, 2020	SELL	$73.37 - $98.18 $11.1 Million - $14.9 Million	-151,400 Reduced 13.91%	937,000 $92 Million
Q1 2020 May 13, 2020	SELL	$64.5 - $97.79 $8.24 Million - $12.5 Million	-127,800 Reduced 10.51%	1,088,400 $82.9 Million
Q4 2019 Feb 12, 2020	BUY	$72.13 - $90.25 $24.3 Million - $30.5 Million	337,400 Added 38.39%	1,216,200 $108 Million
Q3 2019 Nov 12, 2019	SELL	$62.98 - $75.72 $5.69 Million - $6.84 Million	-90,300 Reduced 9.32%	878,800 $66.5 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $20.7 Million - $26.4 Million	314,800 Added 48.11%	969,100 $70.5 Million
Q1 2019 May 14, 2019	BUY	$77.14 - $90.79 $45.8 Million - $53.9 Million	593,600 Added 977.92%	654,300 $52.7 Million
Q4 2018 Feb 13, 2019	SELL	$77.85 - $96.01 $1.79 Million - $2.21 Million	-23,000 Reduced 27.48%	60,700 $5.6 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $4.43 Million - $4.92 Million	49,800 Added 146.9%	83,700 $7.92 Million
Q2 2018 Aug 14, 2018	SELL	$89.78 - $106.23 $17.2 Million - $20.3 Million	-191,100 Reduced 84.93%	33,900 $3.14 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $4.48 Million - $4.91 Million	50,000 Added 28.57%	225,000 $21.8 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $6.98 Million - $8.92 Million	-100,000 Reduced 36.36%	175,000 $15.6 Million
Q2 2017 Aug 14, 2017	BUY	N/A	275,000	275,000 $19.9 Million

Others Institutions Holding ABBV

# of Institutions

3,855

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account